Shionogi & Co Ltd ADR (SGIOY)
Shionogi & Co Ltd ADR is a depositary receipt listed on OTC Markets and linked to the common stock of Shionogi & Co., Ltd., a Japanese pharmaceutical company. The underlying issuer develops, manufactures, and distributes medicines, diagnostic reagents, and medical devices in Japan and in international markets. Shionogi was founded in 1878, adopted its current name in 1943, and is headquartered in Osaka, Japan. As an ADR, this security provides U.S. market participants with a listed representation of the foreign issuer’s common shares rather than a direct common equity listing.
Stock Summary
Fair Value
Profitability & Growth
Quality & Risk
Events & Dividends
Technical Outlook
FAQ
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
Data update note:
Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
OTC-SGIO.Y
|
$9.81
|
10.4% Upside
|
Fair
|
$12.30
|
38.4% Upside
|
Undervalued
|
Great
|
—
|
—
|
—
|
0.0%
|
August 3, 2026
|
11.9x
|
1.5x
|
4.9x
|
15.171 B
|
9.748 B
|
21.8%
|
100.0%
|
9.1
|
27.4%
|
97.1%
|
